AVITA Medical, Inc.
AVITA Medical, Inc. (RCEL) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · RCEL · as of Sep 30, 2025
Ownership Breakdown
81
Institutional Holders
▼ 1 vs Q2
$26.56M
Total Inst. Value
▼ $14.09M vs Q2
24.84M
Shares Outstanding
freeFloat 96.47%
5.20M
13F Shares Held
▼ 2.49M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
RCEL largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC surgical & medical instruments & apparatus | 1.37M | 5.18% | 5.18% | $6.98B | Nov 7, 2025 | ▼ 84.9K |
BLACKROCK, INC. surgical & medical instruments & apparatus | 1.14M | 4.32% | 4.32% | $5.82B | Nov 12, 2025 | ▼ 757.2K |
STATE STREET CORP surgical & medical instruments & apparatus | 423.3K | 1.61% | 1.61% | $2.16B | Nov 14, 2025 | ▼ 105.5K |
GEODE CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 331.5K | 1.26% | 1.26% | $1.69B | Nov 12, 2025 | ▼ 286.9K |
NORTHERN TRUST CORP surgical & medical instruments & apparatus | 172.8K | 65.53% | 65.53% | $882.89M | Nov 14, 2025 | ▼ 86.8K |
MILLENNIUM MANAGEMENT LLC surgical & medical instruments & apparatus | 132.7K | 50.33% | 50.33% | $678.14M | Nov 14, 2025 | ▼ 236.5K |
AQR CAPITAL MANAGEMENT LLC surgical & medical instruments & apparatus | 119.3K | 45.24% | 45.24% | $609.56M | Nov 14, 2025 | ▲ 97.4K |
BRIDGEWAY CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 118.0K | 44.75% | 44.75% | $603.00M | Nov 14, 2025 | ▲ 80.4K |
GOLDMAN SACHS GROUP INC surgical & medical instruments & apparatus | 116.8K | 44.31% | 44.31% | $597.08M | Nov 14, 2025 | ▲ 23.2K |
DIVISADERO STREET CAPITAL MANAGEMENT, LP surgical & medical instruments & apparatus | 100.0K | 37.93% | 37.93% | $511.00M | Nov 14, 2025 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
11
Increased
+330.6K shares9
New Positions
first time holders25
Decreased
−2.22M shares0
Sold Out
fully exitedNet shares change (top 50)
1.89M
+330.6K / −2.22M
Net new holders
-5
9 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
RCEL insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
6
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Woody Joseph Fralin director | Jun 3, 2026 | Purchase | 5,000 | $4.09 | $20.4K | 92.8K | Form 4 ↗ |
Woody Joseph Fralin director | Jun 3, 2026 | Purchase | 5,000 | $4.10 | $20.5K | 87.8K | Form 4 ↗ |
McNamara Robert director | Jan 20, 2026 | Award | 22,214 | — | — | 109.0K | Form 4 ↗ |
McNamara Robert director | Jan 20, 2026 | Award | 16,133 | $3.77 | $60.8K | 16.1K | Form 4 ↗ |
Woody Joseph Fralin director | Jan 20, 2026 | Award | 22,214 | — | — | 82.8K | Form 4 ↗ |
Woody Joseph Fralin director | Jan 5, 2026 | Award | 40,547 | — | — | 60.5K | Form 4 ↗ |
Woody Joseph Fralin director | Jan 5, 2026 | Award | 29,446 | $3.47 | $102.2K | 29.4K | Form 4 ↗ |
Woody Joseph Fralin director | Jan 20, 2026 | Award | 16,133 | $3.77 | $60.8K | 16.1K | Form 4 ↗ |
Tarnoff Michael E director | Jan 20, 2026 | Award | 22,214 | — | — | 48.5K | Form 4 ↗ |
Tarnoff Michael E director | Aug 6, 2025 | Award | 26,250 | — | — | 26.3K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
AVITA Medical, Inc. (RCEL) is primarily owned by institutional investors, who hold approximately 20.9% of total shares outstanding. Company insiders own approximately 3.53%, while retail and public investors account for the remaining 75.55%.
The largest institutional shareholder of AVITA Medical, Inc. is VANGUARD GROUP INC, holding approximately 1.37 million shares — equal to 5.18% of outstanding shares — as of September 30, 2025.
A total of 81 institutional investors currently hold RCEL stock, with a combined institutional value of approximately $26,556,684 as of the most recent 13F filing period.
Frequently asked questions
RCEL ownershipAVITA Medical, Inc. (RCEL) is primarily owned by institutional investors, who hold approximately 20.9% of shares. The largest shareholder is VANGUARD GROUP INC with a 5.18% stake. Company insiders hold 3.53%. Data sourced from SEC Form 13F as of September 30, 2025.